TOBRAMYCIN (TOBRAMYCIN SULFATE) — all Canadian products
19 DINs
10 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is TOBRAMYCIN (TOBRAMYCIN SULFATE), with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02389622 | TEVA-TOBRAMYCIN | TEVA CANADA LIMITED | Solution | Inhalation | TOBRAMYCIN (TOBRAMYCIN SULFATE) 60 MG | Marketed | |
| 02239630 | TOBI | BGP PHARMA ULC | Solution | Inhalation | TOBRAMYCIN (TOBRAMYCIN SULFATE) 300 MG | Marketed | |
| 00533688 | TOBRAMYCIN FOR INJECTION | FRESENIUS KABI CANADA LTD | Powder For Solution | Intravenous | TOBRAMYCIN (TOBRAMYCIN SULFATE) 1.2 G | Marketed | |
| 02457563 | TOBRAMYCIN INHALATION SOLUTION USP | LABORATOIRE RIVA INC. | Solution | Inhalation | TOBRAMYCIN (TOBRAMYCIN SULFATE) 300 MG | Approved | |
| 02533103 | TOBRAMYCIN INJECTION USP | JAMP PHARMA CORPORATION | Solution | Intramuscular; Intravenous | TOBRAMYCIN (TOBRAMYCIN SULFATE) 40 MG | Marketed | |
| 02241209 | TOBRAMYCIN INJECTION USP | SANDOZ CANADA INCORPORATED | Solution | Intravenous; Intramuscular | TOBRAMYCIN (TOBRAMYCIN SULFATE) 10 MG | Marketed | |
| 02241210 | TOBRAMYCIN INJECTION USP | SANDOZ CANADA INCORPORATED | Solution | Intravenous; Intramuscular | TOBRAMYCIN (TOBRAMYCIN SULFATE) 40 MG | Marketed | |
| 02502364 | TOBRAMYCIN INJECTION USP | STERIMAX INC | Solution | Intramuscular; Intravenous | TOBRAMYCIN (TOBRAMYCIN SULFATE) 10 MG | Approved | |
| 02502372 | TOBRAMYCIN INJECTION USP | STERIMAX INC | Solution | Intravenous; Intramuscular | TOBRAMYCIN (TOBRAMYCIN SULFATE) 40 MG | Marketed | |
| 02230640 | TOBRAMYCIN INJECTION, USP | FRESENIUS KABI CANADA LTD | Solution | Intramuscular; Intravenous | TOBRAMYCIN (TOBRAMYCIN SULFATE) 40 MG | Marketed | |
| 02420287 | JAMP-TOBRAMYCIN | JAMP PHARMA CORPORATION | Solution | Intravenous; Intramuscular | TOBRAMYCIN (TOBRAMYCIN SULFATE) 40 MG | Cancelled Post Market | |
| 00325457 | NEBCIN INJ 10MG/ML | ELI LILLY CANADA INC | Liquid | Intravenous; Intramuscular | TOBRAMYCIN (TOBRAMYCIN SULFATE) 10 MG | Cancelled Post Market | |
| 00851825 | NEBCIN INJ 10MG/ML (VANTAGE VIAL) | ELI LILLY CANADA INC | Liquid | Intravenous | TOBRAMYCIN (TOBRAMYCIN SULFATE) 10 MG | Cancelled Post Market | |
| 00325449 | NEBCIN INJ 40MG/ML | ELI LILLY CANADA INC | Liquid | Intravenous; Intramuscular | TOBRAMYCIN (TOBRAMYCIN SULFATE) 40 MG | Cancelled Post Market | |
| 00375764 | NEBCIN INJ 60MG | ELI LILLY CANADA INC | Liquid | Intramuscular; Intravenous | TOBRAMYCIN (TOBRAMYCIN SULFATE) 60 MG | Cancelled Post Market | |
| 00381969 | NEBCIN INJ 80MG | ELI LILLY CANADA INC | Liquid | Intramuscular; Intravenous | TOBRAMYCIN (TOBRAMYCIN SULFATE) 80 MG | Cancelled Post Market | |
| 02285150 | TOBRAMYCIN FOR INJECTION USP | STERIMAX INC | Powder For Solution | Intravenous | TOBRAMYCIN (TOBRAMYCIN SULFATE) 1.2 G | Dormant | |
| 02443368 | TOBRAMYCIN INHALATION SOLUTION | SANDOZ CANADA INCORPORATED | Solution | Inhalation | TOBRAMYCIN (TOBRAMYCIN SULFATE) 300 MG | Cancelled Post Market | |
| 02230639 | TOBRAMYCIN INJECTION | FRESENIUS KABI CANADA LTD | Solution | Intramuscular; Intravenous | TOBRAMYCIN (TOBRAMYCIN SULFATE) 10 MG | Cancelled Post Market |
Browse other molecules: